Literature DB >> 21372386

Protective effects of exogenous glutathione and related thiol compounds against drug-induced liver injury.

Yasuhiro Masubuchi1, Junpei Nakayama, Yuka Sadakata.   

Abstract

An overdose of acetaminophen (APAP) causes liver injury both in experimental animals and humans. N-acetylcysteine (NAC) is clinically used as an antidote for APAP intoxication, and it is thought to act by providing cysteine as a precursor of glutathione, which traps a reactive metabolite of APAP. Other hepatoprotective mechanisms of NAC have also been suggested. Here, we examined the effects of thiol compounds with different abilities to restore hepatic glutathione, on hepatotoxicity of APAP and furosemide in mice. Overnight-fasted male CD-1 mice were given APAP or furosemide intraperitoneally. NAC, cysteine, glutathione, or glutathione-monoethyl ester was administered concomitantly with APAP or furosemide. All thiol compounds used in this study effectively protected mice against APAP-induced liver injury. Only glutathione-monoethyl ester completely prevented APAP-induced early hepatic glutathione depletion. Cysteine also significantly restored hepatic glutathione levels. NAC partially restored glutathione levels. Exogenous glutathione had no effect on hepatic glutathione loss. NAC and glutathione highly stimulated the hepatic expression of cytokines, particularly interleukin-6, which might be involved in the alleviation of APAP hepatotoxicity. Furosemide-induced liver injury, which does not accompany hepatic glutathione depletion, was also attenuated by NAC and exogenous glutathione, supporting their protective mechanisms other than replenishment of glutathione. In conclusion, exogenous thiols could alleviate drug-induced liver injury. NAC and glutathione might exert their effects, at least partially, via mechanisms that are independent of increasing hepatic glutathione, but probably act through cytokine-mediated and anti-inflammatory mechanisms.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21372386     DOI: 10.1248/bpb.34.366

Source DB:  PubMed          Journal:  Biol Pharm Bull        ISSN: 0918-6158            Impact factor:   2.233


  9 in total

1.  Effects of Enzyme Induction and/or Glutathione Depletion on Methimazole-Induced Hepatotoxicity in Mice and the Protective Role of N-Acetylcysteine.

Authors:  Reza Heidari; Hossein Babaei; Leila Roshangar; Mohammad Ali Eghbal
Journal:  Adv Pharm Bull       Date:  2013-12-23

Review 2.  The role of ions, heavy metals, fluoride, and agrochemicals: critical evaluation of potential aetiological factors of chronic kidney disease of multifactorial origin (CKDmfo/CKDu) and recommendations for its eradication.

Authors:  Sunil J Wimalawansa
Journal:  Environ Geochem Health       Date:  2015-10-13       Impact factor: 4.609

3.  Intravenous N-acetylcysteine in pediatric patients with nonacetaminophen acute liver failure: a placebo-controlled clinical trial.

Authors:  Robert H Squires; Anil Dhawan; Estella Alonso; Michael R Narkewicz; Benjamin L Shneider; Norberto Rodriguez-Baez; Dominic Dell Olio; Saul Karpen; John Bucuvalas; Steven Lobritto; Elizabeth Rand; Philip Rosenthal; Simon Horslen; Vicky Ng; Girish Subbarao; Nanda Kerkar; David Rudnick; M James Lopez; Kathleen Schwarz; Rene Romero; Scott Elisofon; Edward Doo; Patricia R Robuck; Sharon Lawlor; Steven H Belle
Journal:  Hepatology       Date:  2013-02-04       Impact factor: 17.425

4.  The Reg3α (HIP/PAP) Lectin Suppresses Extracellular Oxidative Stress in a Murine Model of Acute Liver Failure.

Authors:  Nicolas Moniaux; Marion Darnaud; Kévin Garbin; Alexandre Dos Santos; Catherine Guettier; Didier Samuel; Gilles Amouyal; Paul Amouyal; Christian Bréchot; Jamila Faivre
Journal:  PLoS One       Date:  2015-05-04       Impact factor: 3.240

5.  Amodiaquine-induced toxicity in isolated rat hepatocytes and the cytoprotective effects of taurine and/or N-acetyl cysteine.

Authors:  R Heidari; H Babaei; M A Eghbal
Journal:  Res Pharm Sci       Date:  2014 Mar-Apr

6.  Efficacy of free glutathione and niosomal glutathione in the treatment of acetaminophen-induced hepatotoxicity in cats.

Authors:  L A Denzoin Vulcano; O Confalonieri; R Franci; M O Tapia; A L Soraci
Journal:  Open Vet J       Date:  2013-06-08

7.  CSH guidelines for the diagnosis and treatment of drug-induced liver injury.

Authors:  Yue-Cheng Yu; Yi-Min Mao; Cheng-Wei Chen; Jin-Jun Chen; Jun Chen; Wen-Ming Cong; Yang Ding; Zhong-Ping Duan; Qing-Chun Fu; Xiao-Yan Guo; Peng Hu; Xi-Qi Hu; Ji-Dong Jia; Rong-Tao Lai; Dong-Liang Li; Ying-Xia Liu; Lun-Gen Lu; Shi-Wu Ma; Xiong Ma; Yue-Min Nan; Hong Ren; Tao Shen; Hao Wang; Ji-Yao Wang; Tai-Ling Wang; Xiao-Jin Wang; Lai Wei; Qing Xie; Wen Xie; Chang-Qing Yang; Dong-Liang Yang; Yan-Yan Yu; Min-de Zeng; Li Zhang; Xin-Yan Zhao; Hui Zhuang
Journal:  Hepatol Int       Date:  2017-04-12       Impact factor: 6.047

Review 8.  Drug-Induced Liver Injury: Clinical Evidence of N-Acetyl Cysteine Protective Effects.

Authors:  Yonela Ntamo; Khanyisani Ziqubu; Nireshni Chellan; Bongani B Nkambule; Tawanda M Nyambuya; Sithandiwe E Mazibuko-Mbeje; Kwazikwakhe B Gabuza; Fabio Marcheggiani; Luca Tiano; Phiwayinkosi V Dludla
Journal:  Oxid Med Cell Longev       Date:  2021-12-06       Impact factor: 6.543

Review 9.  Metabolomics profiles in acute-on-chronic liver failure: Unveiling pathogenesis and predicting progression.

Authors:  Guofeng Liu; Xiaoze Wang; Xiaoli Fan; Xuefeng Luo
Journal:  Front Pharmacol       Date:  2022-08-19       Impact factor: 5.988

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.